Page 12 - Stephen Schultz News Today

New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, welcomed a study published in the New England Journal of Medicine yesterday, which showed signals of positive activity in COMP360 psilocybin compared with the standard antidepressant es...

COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO and Co‑founder, and Lars Wilde, President, Chief Business Officer, and Co‑founder, will present a corporate update at 8:00am ET on 15 April at the 20 th Annual Needham Virtual Healthcare Conference. Members of the C...

COMPASS Pathfinder Ltd.: COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference London, UK, April 09, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will present a corporate update at 8:00am ET on ...

COMPASS Pathfinder Ltd.: COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK - 1 April 2021 COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has appointed Wayne J Riley MD to its Board of Directors. Dr Riley is President of the State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, where he holds te...

Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies...

(2) Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre of Excellence, and expansion of Discovery Center Phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression (TRD) on track to report data by end of 2021 First Centre of Excellence, a research facility and innovation lab, established at Sheppard Pratt (Baltimore, Maryland, US) Discovery Center expanded into network of world-leading scientists developi...

Greenlight eyes 2021 expansion as it moves into more areas Brian Sharp, Rochester Democrat and Chronicle © Provided photo Greenlight Networks has moved into new headquarters offices from University Avenue in Rochester to a larger space on East Henrietta Road in Henrietta. Greenlight Networks is freshly ensconced in its new Henrietta headquarters, hiring and looking for a busy year ahead. "You are going to see a lot more activity out of us," President and CEO Mark Murphy said ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. COMPASS Pathways expands its Discovery Center through new collaborations with world-leading ... Compass PathwaysFebruary 9, 2021 GMT COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic compounds at the virtual Discovery Center London, UK – 9 February 2021 COMPASS Pat...

COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy COMPASS Pathways announces publication in of paper on therapist training programme for psilocybin therapy Formal and scalable methodology for psychological support in psilocybin therapy London, UK 3 February 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has shared details...

Compass Pathways: COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy Frontiers in Psychiatry Formal and scalable methodology for psychological support in psilocybin therapy London, UK - 3 February 2021 COMPASS Pathways plc today. The programme sets out a formal and scalable methodology for psychological support in psilocybin therapy. It is currently being used to train therapists taking part in COMPASSs phase IIb cl...